A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.

Cutis; cutaneous medicine for the practitioner

Volumn 69, Issue 2 Suppl, 2002, Pages 4-11

  Webster, Guy F ^a   Guenther, Lyn ^a   Poulin, Yves P ^a   Solomon, Barry A ^a   Loven, Keith ^a   Lee, Jeff ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPALENE; DERMATOLOGICAL AGENT; NAPHTHALENE DERIVATIVE; NICOTINIC ACID DERIVATIVE; TAZAROTENE;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CANADA; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DOUBLE BLIND PROCEDURE; ECONOMICS; FEMALE; GEL; HOSPITALIZATION; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; SKIN DISEASE; TREATMENT OUTCOME; UNITED STATES;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; CHILD; COST-BENEFIT ANALYSIS; DERMATOLOGIC AGENTS; DOUBLE-BLIND METHOD; FACIAL DERMATOSES; FEMALE; GELS; HUMANS; MALE; NAPHTHALENES; NICOTINIC ACIDS; ONTARIO; PENNSYLVANIA; SEVERITY OF ILLNESS INDEX; TENNESSEE; TREATMENT OUTCOME;

EID: 0036479373     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)